Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
B Vitamins and Their Combination Could Reduce Migraine Headaches: A Randomized Double-Blind Controlled Trial Publisher



Nematgorgani S1, 2 ; Razeghijahromi S1, 2 ; Jafari E3 ; Togha M3, 4 ; Rafiee P3 ; Ghorbani Z5, 6 ; Ahmadi ZS7 ; Baigi V8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition and Dietetics, School of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Headache Department, Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Headache Department, Neurology Ward, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Cardiovascular Diseases Research Center, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  6. 6. Department of Clinical Nutrition, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  7. 7. Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Journal of Neurology Published:2022


Abstract

Background: The B vitamins can potentially help prevent migraine. This study was designed to examine the effects of supplementation with thiamine (B1), pyridoxine (B6), cobalamin (B12), folic acid (B9), and a combination of these vitamins on women with episodic migraine (EM). Methods: This study was a double-blind, placebo-controlled, randomized, clinical trial conducted on 120 women with EM. The participants were divided into the 6 groups of B1 (n = 20), B6 (n = 20), B12 (n = 20), B9 (n = 20), vitamin B complex (n = 20), and placebo (n = 20). Subjects received 1 capsule daily for 12 weeks. As part of the baseline and post-intervention phases, paper-based headache diaries were used to record the number of abortive drugs consumed and the frequency of headache attacks, and the Migraine Disability Assessment Questionnaire (MIDAS) was used to assess migraine disability. © 2022 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences.
Other Related Docs
23. Dietary Supplementation in Migraine: A Focus on Omega-3 Fatty Acids, Treatments# Nutraceuticals# Supplements# and Herbal Medicine in Neurological Disorders (2023)